Global Gastroparesis Drugs Market Research Report 2023(Status and Outlook)
Report Overview
Medications are used to try to help reduce symptoms of gastroparesis. The drug categories commonly used are prokinetic (promotility) agents and antiemetic agents.
North America is the largest consumer of Gastroparesis Drugs in global market.The second place is Europe, following North America.
Market is not concentrated. Sumitomo, Cadila Pharmaceuticals, Sanofi, Teva and Johnson & Johnsonare the leaders of the industry, and hold the key technologies and patent, with high-end customers.
The Global Gastroparesis Drugs Market Size was estimated at USD 5438.20 million in 2022 and is projected to reach USD 7302.06 million by 2029, exhibiting a CAGR of 4.30% during the forecast period.
Bosson Research’s latest report provides a deep insight into the global Gastroparesis Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Gastroparesis Drugs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Gastroparesis Drugs market in any manner.
Global Gastroparesis Drugs Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Sumitomo
Cadila Pharmaceuticals
Sanofi
Teva
Johnson & Johnson
Pfizer
Kyowa Kirin Pharmaceuticals
Hanmi Pharm
Ani Pharmaceuticals
Market Segmentation (by Type)
Prokinetic Agents
Antiemetic Agents
Others
Market Segmentation (by Application)
Hospitals
Clinics
Ambulatory Surgical Centers
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Gastroparesis Drugs Market
Overview of the regional outlook of the Gastroparesis Drugs Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
- 1 Research Methodology and Statistical Scope
- 1.1 Market Definition and Statistical Scope of Gastroparesis Drugs
- 1.2 Key Market Segments
- 1.2.1 Gastroparesis Drugs Segment by Type
- 1.2.2 Gastroparesis Drugs Segment by Application
- 1.3 Methodology & Sources of Information
- 1.3.1 Research Methodology
- 1.3.2 Research Process
- 1.3.3 Market Breakdown and Data Triangulation
- 1.3.4 Base Year
- 1.3.5 Report Assumptions & Caveats
- 2 Gastroparesis Drugs Market Overview
- 2.1 Global Market Overview
- 2.1.1 Global Gastroparesis Drugs Market Size (M USD) Estimates and Forecasts (2018-2029)
- 2.1.2 Global Gastroparesis Drugs Sales Estimates and Forecasts (2018-2029)
- 2.2 Market Segment Executive Summary
- 2.3 Global Market Size by Region
- 3 Gastroparesis Drugs Market Competitive Landscape
- 3.1 Global Gastroparesis Drugs Sales by Manufacturers (2018-2023)
- 3.2 Global Gastroparesis Drugs Revenue Market Share by Manufacturers (2018-2023)
- 3.3 Gastroparesis Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.4 Global Gastroparesis Drugs Average Price by Manufacturers (2018-2023)
- 3.5 Manufacturers Gastroparesis Drugs Sales Sites, Area Served, Product Type
- 3.6 Gastroparesis Drugs Market Competitive Situation and Trends
- 3.6.1 Gastroparesis Drugs Market Concentration Rate
- 3.6.2 Global 5 and 10 Largest Gastroparesis Drugs Players Market Share by Revenue
- 3.6.3 Mergers & Acquisitions, Expansion
- 4 Gastroparesis Drugs Industry Chain Analysis
- 4.1 Gastroparesis Drugs Industry Chain Analysis
- 4.2 Market Overview of Key Raw Materials
- 4.3 Midstream Market Analysis
- 4.4 Downstream Customer Analysis
- 5 The Development and Dynamics of Gastroparesis Drugs Market
- 5.1 Key Development Trends
- 5.2 Driving Factors
- 5.3 Market Challenges
- 5.4 Market Restraints
- 5.5 Industry News
- 5.5.1 New Product Developments
- 5.5.2 Mergers & Acquisitions
- 5.5.3 Expansions
- 5.5.4 Collaboration/Supply Contracts
- 5.6 Industry Policies
- 6 Gastroparesis Drugs Market Segmentation by Type
- 6.1 Evaluation Matrix of Segment Market Development Potential (Type)
- 6.2 Global Gastroparesis Drugs Sales Market Share by Type (2018-2023)
- 6.3 Global Gastroparesis Drugs Market Size Market Share by Type (2018-2023)
- 6.4 Global Gastroparesis Drugs Price by Type (2018-2023)
- 7 Gastroparesis Drugs Market Segmentation by Application
- 7.1 Evaluation Matrix of Segment Market Development Potential (Application)
- 7.2 Global Gastroparesis Drugs Market Sales by Application (2018-2023)
- 7.3 Global Gastroparesis Drugs Market Size (M USD) by Application (2018-2023)
- 7.4 Global Gastroparesis Drugs Sales Growth Rate by Application (2018-2023)
- 8 Gastroparesis Drugs Market Segmentation by Region
- 8.1 Global Gastroparesis Drugs Sales by Region
- 8.1.1 Global Gastroparesis Drugs Sales by Region
- 8.1.2 Global Gastroparesis Drugs Sales Market Share by Region
- 8.2 North America
- 8.2.1 North America Gastroparesis Drugs Sales by Country
- 8.2.2 U.S.
- 8.2.3 Canada
- 8.2.4 Mexico
- 8.3 Europe
- 8.3.1 Europe Gastroparesis Drugs Sales by Country
- 8.3.2 Germany
- 8.3.3 France
- 8.3.4 U.K.
- 8.3.5 Italy
- 8.3.6 Russia
- 8.4 Asia Pacific
- 8.4.1 Asia Pacific Gastroparesis Drugs Sales by Region
- 8.4.2 China
- 8.4.3 Japan
- 8.4.4 South Korea
- 8.4.5 India
- 8.4.6 Southeast Asia
- 8.5 South America
- 8.5.1 South America Gastroparesis Drugs Sales by Country
- 8.5.2 Brazil
- 8.5.3 Argentina
- 8.5.4 Columbia
- 8.6 Middle East and Africa
- 8.6.1 Middle East and Africa Gastroparesis Drugs Sales by Region
- 8.6.2 Saudi Arabia
- 8.6.3 UAE
- 8.6.4 Egypt
- 8.6.5 Nigeria
- 8.6.6 South Africa
- 9 Key Companies Profile
- 9.1 Sumitomo
- 9.1.1 Sumitomo Gastroparesis Drugs Basic Information
- 9.1.2 Sumitomo Gastroparesis Drugs Product Overview
- 9.1.3 Sumitomo Gastroparesis Drugs Product Market Performance
- 9.1.4 Sumitomo Business Overview
- 9.1.5 Sumitomo Gastroparesis Drugs SWOT Analysis
- 9.1.6 Sumitomo Recent Developments
- 9.2 Cadila Pharmaceuticals
- 9.2.1 Cadila Pharmaceuticals Gastroparesis Drugs Basic Information
- 9.2.2 Cadila Pharmaceuticals Gastroparesis Drugs Product Overview
- 9.2.3 Cadila Pharmaceuticals Gastroparesis Drugs Product Market Performance
- 9.2.4 Cadila Pharmaceuticals Business Overview
- 9.2.5 Cadila Pharmaceuticals Gastroparesis Drugs SWOT Analysis
- 9.2.6 Cadila Pharmaceuticals Recent Developments
- 9.3 Sanofi
- 9.3.1 Sanofi Gastroparesis Drugs Basic Information
- 9.3.2 Sanofi Gastroparesis Drugs Product Overview
- 9.3.3 Sanofi Gastroparesis Drugs Product Market Performance
- 9.3.4 Sanofi Business Overview
- 9.3.5 Sanofi Gastroparesis Drugs SWOT Analysis
- 9.3.6 Sanofi Recent Developments
- 9.4 Teva
- 9.4.1 Teva Gastroparesis Drugs Basic Information
- 9.4.2 Teva Gastroparesis Drugs Product Overview
- 9.4.3 Teva Gastroparesis Drugs Product Market Performance
- 9.4.4 Teva Business Overview
- 9.4.5 Teva Gastroparesis Drugs SWOT Analysis
- 9.4.6 Teva Recent Developments
- 9.5 Johnson andamp; Johnson
- 9.5.1 Johnson andamp; Johnson Gastroparesis Drugs Basic Information
- 9.5.2 Johnson andamp; Johnson Gastroparesis Drugs Product Overview
- 9.5.3 Johnson andamp; Johnson Gastroparesis Drugs Product Market Performance
- 9.5.4 Johnson andamp; Johnson Business Overview
- 9.5.5 Johnson andamp; Johnson Gastroparesis Drugs SWOT Analysis
- 9.5.6 Johnson andamp; Johnson Recent Developments
- 9.6 Pfizer
- 9.6.1 Pfizer Gastroparesis Drugs Basic Information
- 9.6.2 Pfizer Gastroparesis Drugs Product Overview
- 9.6.3 Pfizer Gastroparesis Drugs Product Market Performance
- 9.6.4 Pfizer Business Overview
- 9.6.5 Pfizer Recent Developments
- 9.7 Kyowa Kirin Pharmaceuticals
- 9.7.1 Kyowa Kirin Pharmaceuticals Gastroparesis Drugs Basic Information
- 9.7.2 Kyowa Kirin Pharmaceuticals Gastroparesis Drugs Product Overview
- 9.7.3 Kyowa Kirin Pharmaceuticals Gastroparesis Drugs Product Market Performance
- 9.7.4 Kyowa Kirin Pharmaceuticals Business Overview
- 9.7.5 Kyowa Kirin Pharmaceuticals Recent Developments
- 9.8 Hanmi Pharm
- 9.8.1 Hanmi Pharm Gastroparesis Drugs Basic Information
- 9.8.2 Hanmi Pharm Gastroparesis Drugs Product Overview
- 9.8.3 Hanmi Pharm Gastroparesis Drugs Product Market Performance
- 9.8.4 Hanmi Pharm Business Overview
- 9.8.5 Hanmi Pharm Recent Developments
- 9.9 Ani Pharmaceuticals
- 9.9.1 Ani Pharmaceuticals Gastroparesis Drugs Basic Information
- 9.9.2 Ani Pharmaceuticals Gastroparesis Drugs Product Overview
- 9.9.3 Ani Pharmaceuticals Gastroparesis Drugs Product Market Performance
- 9.9.4 Ani Pharmaceuticals Business Overview
- 9.9.5 Ani Pharmaceuticals Recent Developments
- 10 Gastroparesis Drugs Market Forecast by Region
- 10.1 Global Gastroparesis Drugs Market Size Forecast
- 10.2 Global Gastroparesis Drugs Market Forecast by Region
- 10.2.1 North America Market Size Forecast by Country
- 10.2.2 Europe Gastroparesis Drugs Market Size Forecast by Country
- 10.2.3 Asia Pacific Gastroparesis Drugs Market Size Forecast by Region
- 10.2.4 South America Gastroparesis Drugs Market Size Forecast by Country
- 10.2.5 Middle East and Africa Forecasted Consumption of Gastroparesis Drugs by Country
- 11 Forecast Market by Type and by Application (2024-2029)
- 11.1 Global Gastroparesis Drugs Market Forecast by Type (2024-2029)
- 11.1.1 Global Forecasted Sales of Gastroparesis Drugs by Type (2024-2029)
- 11.1.2 Global Gastroparesis Drugs Market Size Forecast by Type (2024-2029)
- 11.1.3 Global Forecasted Price of Gastroparesis Drugs by Type (2024-2029)
- 11.2 Global Gastroparesis Drugs Market Forecast by Application (2024-2029)
- 11.2.1 Global Gastroparesis Drugs Sales (K MT) Forecast by Application
- 11.2.2 Global Gastroparesis Drugs Market Size (M USD) Forecast by Application (2024-2029)
- 12 Conclusion and Key Findings
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook